Hims & Hers enters the weight loss market, but takes a conservative approach

The new platform has now launched just in time for New Year's resolutions, but relies on generics rather than the very popular GLP-1 drugs. Hims & Hers announced in August that it would enter the weight loss market by the end of the year. The company's new weight management program has been in research and development for over a year. Now it could be launched this week, but instead of prescribing Ozempic and Wegovy, the telemedicine company will take a conservative approach and instead focus on a range of generics, nutritional benefits and...